Page Arthur B Gilead Sciences, Inc. Transaction History

Page Arthur B

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $238,830 - $311,655	-3,945 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $534,956 - $592,294	-7,505 Reduced 65.55%	3,945 $305,000
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $53,525 - $62,436	-825 Reduced 6.72%	11,450 $812,000
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $16,364 - $19,209	230 Added 1.91%	12,275 $880,000
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $868,564 - $1.03 Million	12,045	12,045 $976,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Page Arthur B, based on Form 13F filings with the SEC.

Stay updated on Page Arthur B with notifications on news.